ConductScience.org, home

Paper32130706

The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response.

Hipólito A and 2 others. Adv Exp Med Biol, 2020. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response. Papers, record 32130706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32130706

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response.
PubMed
Journal
Adv Exp Med Biol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.34
iCite
Revised in PubMed
2024-02-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hipólito AAna
2Mendes CCindy
3Serpa JJacinta

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lung NeoplasmsMajor topic
Humans
Immunotherapy
Molecular Targeted Therapy
Tumor Microenvironment

References156

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128254693TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation.Biomaterials2017https://conductscience.org/library/papers/28254693PubMed
222913968Glucose transporters in cancer metabolism.Curr Opin Oncol2012https://conductscience.org/library/papers/22913968PubMed
312833461A Phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma.Cancer2003https://conductscience.org/library/papers/12833461PubMed
430532012The lung microenvironment: an important regulator of tumour growth and metastasis.Nat Rev Cancer2019https://conductscience.org/library/papers/30532012PubMed
525512109Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.BMC Cancer2014https://conductscience.org/library/papers/25512109PubMed
618824264Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression.Mol Immunol2008https://conductscience.org/library/papers/18824264PubMed
726413839Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma.PLoS One2015https://conductscience.org/library/papers/26413839PubMed
826750865The Warburg effect and drug resistance.Br J Pharmacol2016https://conductscience.org/library/papers/26750865PubMed
924138885Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.Immunity2013https://conductscience.org/library/papers/24138885PubMed
1026377897Metabolic Reprogramming of Immune Cells in Cancer Progression.Immunity2015https://conductscience.org/library/papers/26377897PubMed
1121107292The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.J Thorac Oncol2011https://conductscience.org/library/papers/21107292PubMed
1224952473Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells.Oncotarget2014https://conductscience.org/library/papers/24952473PubMed
1327387758Early changes in the metabolic profile of activated CD8(+) T cells.BMC Cell Biol2016https://conductscience.org/library/papers/27387758PubMed
1426321679Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.Cell2015https://conductscience.org/library/papers/26321679PubMed
1528875486Metabolism in Immune Cell Differentiation and Function.Adv Exp Med Biol2017https://conductscience.org/library/papers/28875486PubMed
1623475953Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor.Mol Cancer Res2013https://conductscience.org/library/papers/23475953PubMed
1725056707Non-small-cell lung cancers: a heterogeneous set of diseases.Nat Rev Cancer2014https://conductscience.org/library/papers/25056707PubMed
1825857315New horizons in tumor microenvironment biology: challenges and opportunities.BMC Med2015https://conductscience.org/library/papers/25857315PubMed
1923261227Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.Lung Cancer2013https://conductscience.org/library/papers/23261227PubMed
2029248722Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer.Free Radic Biol Med2018https://conductscience.org/library/papers/29248722PubMed

See all 156 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42435178Targeting Lung Cancer Metabolism: Therapeutic Opportunities and Challenges.Adv Exp Med Biol2026https://conductscience.org/library/papers/42435178PubMed
42435166Glucose and Lactate, Starters or Intermediates of Cancer Metabolic Rewiring.Adv Exp Med Biol2026https://conductscience.org/library/papers/42435166PubMed
38990147Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells.Biosci Rep2024https://conductscience.org/library/papers/38990147PubMed
38628288A metabolomics study on carcinogenesis of ground-glass nodules.Cytojournal2024https://conductscience.org/library/papers/38628288PubMed
38247476H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine.Antioxidants (Basel)2023https://conductscience.org/library/papers/38247476PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32130706

GET https://conductscience.org/api/papers/v1/32130706/references?page=2